We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Texas

News   Apr 12, 2018 | Original story from Lonza

 
Lonza Opens World’s Largest Dedicated Cell-and-Gene-Therapy Manufacturing Facility in Texas

Credit: Lonza

 
 
Advertisement
 

RELATED ARTICLES

Liver Organoid Offers New Promise in Transplantation and the Study of Liver Disease

News

Biologists and bioengineers at EPFL have designed a new method for growing simplified human mini-livers. Their process is a potentially important breakthrough in the quest for transplantable lab-grown tissues.

READ MORE

SARS-CoV-2 Immunity Rapidly Declines Within Months of Infection

News

A recent preprint study indicates that there is a rapid decline in the levels of SARS-CoV-2 neutralizing antibodies during the weeks following initial infection. This raises questions over the potential for re-infection, the effectiveness that may be expected from vaccination and the viable window for antibody testing in disease surveillance.

READ MORE

Why Lopinavir and Hydroxychloroquine Are Ineffective in COVID-19 Patients

News

A research group has discovered that the concentration of lopinavir and hydroxychloroquine in the lungs of COVID-19 patients is not sufficient to fight the virus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE